View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 20, 2022

University of Sydney develops device to detect early signs of heart attack

The new device uses a blood sample to analyse platelet clotting and white cell inflammation responses.

The University of Sydney’s Nano Institute and School of Biomedical Engineering biomedical engineer Dr Arnold Lining Ju is developing a new biomedical micro-device that can detect early signs of a heart attack or stroke.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Developed based on an integrated microfluidic chip, the device can detect subtle platelet changes that occur before a heart attack or stroke takes place.

A blood sample from a person’s finger is collected and analysed for platelet clotting and white cell inflammation responses.

An external operating system can immediately process the result.

The university’s research forms part of a former long-term collaboration with the Heart Research Institute Charles Perkins Centre cardiovascular research director Shaun Jackson.

Lining Ju said: “How this device would work is that an at-risk person, for example, someone with heart disease, would use it daily.

“Using a finger prick test, the device would monitor their blood and alert them to any potentially dangerous changes. If a change was detected, they would need to present for more monitoring at a hospital.”

In Australia, heart attacks and strokes each affect nearly 55,000 people every year.

They are mostly caused by blood clots that block the flow of blood to the heart.

New facilities at the University’s School of Biomedical Engineering will allow further development of the device.

University of Sydney Biomedical Engineering student Yunduo Charles Zhao said: “In the near future, we plan to apply artificial intelligence to understand an individual’s blood work, with the aim of creating a personalised blood profile of that person.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network